Remote Monitoring in Patients With Coronavirus Disease (COVID-19)

Vivek Reddy0 sitesApril 17, 2020

ConditionsCOVID-19 Cardiac Arrhythmias

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: COVID-19
Sponsor: Vivek Reddy
Primary Endpoint: Number of different arrhythmias
Status: Withdrawn
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.

Detailed Description

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.

Registry

clinicaltrials.gov

Start Date

April 17, 2020

End Date

May 1, 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Vivek Reddy

Responsible Party

Sponsor Investigator

Principal Investigator

Vivek Reddy

Professor

Icahn School of Medicine at Mount Sinai

Eligibility Criteria

Inclusion Criteria

•Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either
•Not admitted to the hospital, and permitted to recover at home
•Discharged from inpatient hospitalization, during the acute recovery period
•18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).